Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

105.84
-0.5100-0.48%
Post-market: 105.840.00000.00%19:51 EDT
Volume:730.78K
Turnover:77.31M
Market Cap:3.72B
PE:-1.69
High:107.02
Open:105.98
Low:103.98
Close:106.35
Loading ...

Press Release: Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Avis Budget put volume heavy and directionally bearish

TIPRANKS
·
11 Mar

Q3 2025 America's CAR-MART Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

CAR Group (WN6) Gets a Buy from Citi

TIPRANKS
·
07 Mar

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Business Wire
·
07 Mar

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire
·
06 Mar

Winners And Losers Of Q3: Heartland Express (NASDAQ:HTLD) Vs The Rest Of The Ground Transportation Stocks

StockStory
·
05 Mar

Minority investor says UOI is over-capitalised, and should distribute Haw Par as dividend-in-specie

The Edge Singapore
·
28 Feb

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer

Business Wire
·
28 Feb

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

Business Wire
·
27 Feb

CIBC Announces First Quarter 2025 Results

CNW Group
·
27 Feb

Innovative mRNA-Based CAR-T Therapy Positions Cartesian Therapeutics for Market Leadership

TIPRANKS
·
27 Feb

FIX-IT DAY 2025: FREE CAR REPAIRS FOR LOS ANGELES RESIDENTS IN NEED

PR Newswire
·
26 Feb

Anixa doses first patient in third cohort of Phase 1 clinical trial of CAR-T

TIPRANKS
·
26 Feb

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

PR Newswire
·
26 Feb

Ground Transportation Stocks Q4 In Review: ArcBest (NASDAQ:ARCB) Vs Peers

StockStory
·
26 Feb

Charles River announces CAR T-cells agreement with Singapore General Hospital

TIPRANKS
·
25 Feb

Charles River Announces Agreement with Singapore General Hospital

Business Wire
·
25 Feb

BMO Financial Group Reports First Quarter 2025 Results

PR Newswire
·
25 Feb

Q4 Earnings Roundup: RXO (NYSE:RXO) And The Rest Of The Ground Transportation Segment

StockStory
·
25 Feb